[VITAMIN D AND CHRONIC LUNG COLONIZATION IN PEDIATRIC AND YOUNG ADULTS CYSTIC FIBROSIS PATIENTS]

David González Jiménez1, Rosana Muñoz Codoceo2, María Garriga García3

  • 1Gastroenterología y Nutrición Pediátrica. Hospital Universitario Central de Asturias, Oviedo.. domixixon@gmail.com.

Nutricion Hospitalaria
|November 8, 2015
PubMed

Insights

More than half of Cystic Fibrosis patients have insufficient vitamin D levels. Chronic lung infections, particularly by Pseudomonas and Staphylococcus aureus, significantly increase the risk of vitamin D deficiency, even with supplementation.

Area of Science:

  • Pediatric Pulmonology
  • Nutritional Science
  • Microbiology

Background:

  • Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs, with chronic lung infections being a major cause of morbidity and mortality.
  • Vitamin D deficiency is common in CF patients, potentially impacting immune function and lung health.
  • The relationship between vitamin D status and chronic lung colonization in CF requires further elucidation.

Purpose of the Study:

  • To evaluate vitamin D status in a cohort of Cystic Fibrosis patients.
  • To investigate the association between vitamin D levels and chronic lung colonization by specific pathogens in CF.
  • To identify risk factors for vitamin D deficiency in this population.

Main Methods:

  • A descriptive, cross-sectional, multicenter study was conducted involving 377 CF patients from November 2012 to April 2014.
  • Vitamin D levels were measured, with levels below 30 ng/ml defined as insufficient.
  • Chronic colonization was defined as at least two positive sputum cultures within the preceding year.

Main Results:

  • 65% of the 377 CF patients exhibited insufficient vitamin D levels.
  • An inverse correlation was observed between patient age and vitamin D levels (r = -0.20, p < 0.001).
  • Chronic colonization by Pseudomonas sp. in children/adolescents and Staphylococcus aureus in younger children was associated with an increased risk of vitamin D deficiency, independent of age, screening diagnosis, or pancreatic status.

Conclusions:

  • Over half of the studied CF patients had suboptimal vitamin D levels despite supplementation.
  • Chronic lung colonization by Pseudomonas sp. and S. aureus is a significant risk factor for developing vitamin D deficiency in CF patients.
  • Targeted monitoring and intervention for vitamin D status are crucial in CF patients with chronic lung infections.
Abstract

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
620
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.1K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.1K